Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 30;15(12):e0244499. doi: 10.1371/journal.pone.0244499

The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler

Iliuza R Iaubasarova 1,2, Ljudmila S Khailova 1, Alexander M Firsov 1, Vera G Grivennikova 3, Roman S Kirsanov 1, Galina A Korshunova 1, Elena A Kotova 1, Yuri N Antonenko 1,*
Editor: Oleg Y Dmitriev4
PMCID: PMC7773232  PMID: 33378414

Abstract

The synthesis of a mitochondria-targeted derivative of the classical mitochondrial uncoupler carbonyl cyanide-m-chlorophenylhydrazone (CCCP) by alkoxy substitution of CCCP with n-decyl(triphenyl)phosphonium cation yielded mitoCCCP, which was able to inhibit the uncoupling action of CCCP, tyrphostin A9 and niclosamide on rat liver mitochondria, but not that of 2,4-dinitrophenol, at a concentration of 1–2 μM. MitoCCCP did not uncouple mitochondria by itself at these concentrations, although it exhibited uncoupling action at tens of micromolar concentrations. Thus, mitoCCCP appeared to be a more effective mitochondrial recoupler than 6-ketocholestanol. Both mitoCCCP and 6-ketocholestanol did not inhibit the protonophoric activity of CCCP in artificial bilayer lipid membranes, which might compromise the simple proton-shuttling mechanism of the uncoupling activity on mitochondria.

1. Introduction

It is now generally accepted that electron transfer via a chain of proton pumps in the inner mitochondrial or bacterial membrane results in the formation of a transmembrane difference of electrochemical potentials of hydrogen ions that couples the oxidation of respiratory substrates to ATP synthesis. Compounds that compromise the coupling between respiration and phosphorylation called uncouplers have recently received strong interest as promising anti-cancer, antibacterial, anti-obesity, antidiabetic, neuroprotective and cardioprotective agents [18]. Although the experiments with uncouplers on artificial membranes, mitochondria and bacteria have played a crucial role in the validation of Mitchell’s chemiosmotic theory, the mechanism of uncoupling remains not fully understood. There is so far no consensus whether the uncoupling action occurs with or without the aid of membrane proteins [9], despite the general confidence in the protonophoric nature of this action.

In particular, the recoupling effect of 6-ketocholestanol (kCh) found earlier by Starkov and colleagues [10, 11] was tentatively considered as an evidence in favor of involvement of proteins in mitochondrial uncoupling mediated by such agents as carbonyl cyanide-m-chlorophenylhydrazone (CCCP), carbonyl cyanide p-trifluoromethoxy phenylhydrazone (FCCP) and tyrphostin A9 (SF6847) [9]. This idea was supported by the fact that in planar bilayer lipid membranes, kCh not only failed to reverse the protonophoric action of SF6847, but even enhanced the conductivity increase caused by this uncoupler. Nevertheless, it cannot be excluded that the recoupling action of kCh is somehow associated with its impact on physical properties of membranes, i.e. an increase in the membrane dipole potential [11, 12] and diminution of membrane fluidity [13]. Later, the kCh-induced recoupling was also reported for curcumin derivatives [14], eudesman [15], SR4 [16], a bicyclic hydroquinone [17] and BAM15 [18]. By contrast, kCh was ineffective with 2,4-dinitrophenol (DNP), fatty acids and gramicidin A [11].

To make the impact of uncouplers more selective, i.e. to avoid adverse effects, it is reasonable to design mitochondria-targeted agents. Earlier in the laboratory of Michael Murphy, an attempt was made to obtain a mitochondria-targeted uncoupler based on a conjugate of the popular uncoupler DNP with a triphenylphosphonium (TPP) cation. It was assumed that the addition of a lipophilic cation will provide selective accumulation of the uncoupler in the mitochondria, since energized mitochondria are negatively charged with respect to the cytosol. However, the resulting compound lacked the uncoupling activity [19]. Here, we report synthesis of a mitochondria-targeted derivative of CCCP (a conjugate with TPP coined mitoCCCP), which appeared to be a rather weak uncoupler but exhibited effective inhibition of the CCCP-caused uncoupling in mitochondria.

2. Materials and methods

2.1. Chemicals

Most chemicals, including CCCP, FCCP, DNP, tyrphostin A9 (3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile), niclosamide, rotenone, lasalocid A, diphytanoylphosphatidylcholine (DPhPC), and safranine O were from Sigma.

2.2. Isolation of rat liver mitochondria and mitoplasts

Mitochondria were isolated from rat liver by using differential centrifugation [20], according to a slightly modified procedure previously described [21]. The animals were handled and experiments were performed in accordance with the international guidelines for animal care and use and the Institutional Ethics Committee of A.N. Belozersky Institute of Physico-Chemical Biology at the Lomonosov Moscow State University approved them (protocol #3 on February 12, 2018). To prepare mitoplasts (mitochondria minus outer membrane), freshly purified mitochondria were resuspended in 10 mM-Tris/HCl buffer, pH 7.5 (swelling medium), at a protein concentration of about 10 mg/ml before incubation on ice for 5 min. The mitoplasts were centrifuged and resuspended in the isolation medium and washed twice in the same buffer.

2.3. Preparation of submitochondrial particles from bovine heart

Inside-out coupled SMP of bovine heart mitochondria were prepared and activated as described Bovine heart inside-out submitochondrial particles (SMP) were prepared, activated, and coupled by treatment with oligomycin (0.5 μg/mg of SMP protein), as described in [22].

2.4. Preparation of subbacterial inverted membrane particles (SBP) from Escherichia coli

Subbacterial inverted membrane particles (SBP) from Escherichia coli strain BW25113 were provided by Anna Lapashina (Belozersky Institute, Moscow State University). The particles were prepared as described in [23]. Briefly, after growth cells were washed once with buffer containing 10 mM HEPES-NaOH, pH 7.5, 5 mM MgCl2, and 10% glycerol, resuspended in 25–30 ml of the same buffer, and disrupted by two consecutive passages through a French cell press (SLM Aminco, USA) at 1000 PSI. Unbroken cell debris was collected by 30 min centrifugation at 13,700g and discarded. The supernatant was centrifuged for 1 h at 390,000g, and the SBP pellet was washed with 25 ml of the same buffer and resuspended in the same buffer. The centrifugation was repeated once more, and the SBP pellet was suspended in 1.0–1.5 ml of the same buffer, aliquoted by 50 μl, frozen in liquid nitrogen, and stored at –80°C.

2.5. Mitochondrial respiration

The respiration of isolated rat liver mitochondria was measured at the mitochondrial protein concentration of 0.8 mg/ml by using a Clark-type oxygen electrode (Strathkelvin Instruments, UK), as described previously [21]. The ADP/O ratio was calculated as in [24].

2.6. Membrane potential (ΔΨ) measurement in isolated mitochondria

The mitochondrial membrane potential (ΔΨ) was evaluated from the difference in the absorbance at 555 and 523 nm (ΔA) of the safranine O dye [25] measured with an Aminco DW-2000 spectrophotometer, as described previously [21]. Mitochondria were incubated in the medium containing 250 mM sucrose, 5 mM MOPS, 0.5 mM KH2PO4, 1 mM EGTA, 2 μM rotenone, 5 mM succinate (pH 7.4), 1 μg/ml oligomycin, and 15 μM safranine O at the mitochondrial protein content of 0.7–0.9 mg protein/ml.

2.7. NADH oxidation by submitochondrial particles

NADH oxidase activity of SMP was measured at 340 nm in the mixture composed of 0.25 M sucrose, 50 mM Tris/HCl (pH 8.0), 0.2 mM EDTA at 30°C supplemented by 100 μM NADH. The reaction was initiated by the addition of SMP (10 μg of protein per ml).

2.8. Generation of pH gradient (ΔpH) in submitochondrial particles

Generation of the transmembrane pH gradient in response to NADH addition was measured by following the changes in fluorescence of 9-amino-6-chloro-2-methoxyacridine (ACMA) with a Spectrofluorometer Fluorat-02-Panorama—Lumex Instruments (410 nm emission, 480 nm excitation), as described in [26]. The buffer solution (pH 7.4) contained 10 mM HEPES, 100 mM KCl, 5 mM MgCl2, 0.5 μg/ml ACMA.

2.9. Electrical current through planar bilayers

BLM was formed by the brush technique [27] from 2% diphytanoylphosphatidylcholine (DPhPC) solution in decane on a 0.8 mm aperture in a Teflon septum separating the chamber into two equal compartments (3 ml each). Electrical currents under voltage-clamp conditions were measured with two Ag/AgCl electrodes placed into solutions on each side of BLM via agar bridges (the ground electrode in the cis compartment) using a Keithley 428 amplifier (Keithley Instruments, Cleveland, OH). Transmembrane electrical potentials were measured using Keithley 6517A. All experiments were performed at 23-25°C.

2.10. Detection of proton transport in pyranine-loaded liposomes

The lumenal pH of the liposomes was assayed with pyranine [28] by a slightly modified procedure of [29]. To prepare pyranine-loaded liposomes, lipid (2 mg POPC, 1 mg POPG and 1 mg cholesterol) in a chloroform suspension was dried in a round-bottom flask under a stream of nitrogen. The lipid was then resuspended in buffer (100 mM KCl, 20 mM MES, 20 mM MOPS, 20 mM Tricine titrated with KOH to pH 6.0) containing 0.5 mM pyranine. The suspension was vortexed and then freeze-thawed three times. Unilamellar liposomes were prepared by extrusion through 0.1-μm-pore size Nucleopore polycarbonate membranes using an Avanti Mini-Extruder. The unbound pyranine was then removed by passage through a Sephadex G-50 coarse column equilibrated with the same buffer solution. To measure the rate of pH dissipation in liposomes with lumenal pH 6.0, the liposomes were diluted in solution buffered to pH 8 and supplemented with 2 mM p-xylene-bis-pyridinium bromide to suppress the fluorescence of leaked pyranine. The inner liposomal pH was estimated from the pyranine fluorescence intensity measured at 505 nm upon excitation at 455 nm with the Fluorat-02-Panorama spectrofluorometer. At the end of each recording, 1 μM lasalocid A was added to dissipate the remaining pH gradient. To prevent the formation of H+-diffusion potential, the experiments were carried out in the presence of 10 nM valinomycin.

3. Results and discussion

The synthesis of mitoCCCP, 10-([4’-(dicyanomethylene)hydrazinyl-2’-chlorophenyl]oxy)decyl(triphenyl)phosphonium bromide (Fig 1), started with the synthesis of p-hydroxyCCCP via the reaction of 4-amino-2-chlorophenol with sodium nitrite in HCl followed by the reaction with malononitrile. In particular, the amino group was converted into a diazonium salt by a diazotization reaction, and then a functional group responsible for the uncoupling activity of CCCP was formed by the nucleophilic addition of malononitrile. Finally, the 10-bromodecyl(triphenyl)phosphonium cation obtained by quaternization was attached to the hydroxy group by an O-alkylation reaction (Fig 1). ESI-MS data for p-hydroxyCCCP (S1 Fig in S1 File) and mitoCCCP (S2 Fig in S1 File) can be found in ESI.

Fig 1. A scheme of the synthesis of mitoCCCP, a derivative of the protonophore CCCP (carbonyl cyanide m-chlorophenylhydrazone) targeted to mitochondria by a decyl(triphenyl)phosphonium cation.

Fig 1

Fig 2A illustrates an effect of mitoCCCP (added at t = 60 s) on the membrane potential of isolated rat liver mitochondria (RLM), as measured by changes in absorbance of the potential-sensitive dye safranine O [25]. The addition of 2.5 μМ mitoCCCP to RLM at t = 60 s did not lead to a decrease in the membrane potential (gray curve in Fig 2A), in contrast to СССР (0.2 μМ, black curve in Fig 2A). However, the addition of mitoCCCP at t = 150 s after СССР resulted in restoration of the initial level of the membrane potential observed in the absence of CCCP. The subsequent addition of FCCP at a high concentration (0.5 μМ) again brought about a drop in the membrane potential. If mitoCCCP was added prior to CCCP, the depolarizing effect of CCCP became transient and disappeared in 2 minutes (blue curve). The recoupling effect of mitoCCCP qualitatively resembled that of kCh [10, 11], albeit mitoCCCP effectively recoupled RLM at much lower concentrations than kCh. The dose dependence of the recoupling action of mitoCCCP is shown in S3 Fig in S1 File, while S4 Fig in S1 File shows that the recoupling action of 2.5 μM mitoCCCP remains nearly complete in a wide range of CCCP concentrations except for concentrations exceeding 300 nM. Interestingly the recoupling action of mitoCCCP exhibited transient character in case of mitoplasts, i.e. mitochondria lacking the outer membrane (S5 Fig in S1 File). The initial rise of the membrane potential after the addition of mitoCCCP was followed by a slow decrease lasting several minutes. The recoupling by mitoCCCP was also observed if SF6847 (Fig 2B) or niclosamide (data not shown) were used as mitochondrial uncouplers, although the recoupling was lower than in the case of CCCP. However, the effect of mitoCCCP was absolutely different if DNP was used instead of CCCP: the addition of mitoCCCP did not cause restoration of the membrane potential dropped by DNP. On the contrary, the depolarizing action of DNP was enhanced by mitoCCCP (Fig 2C), which was consistent with our previous data on the interaction of anionic protonophores with lipophilic cations such as decyl(triphenyl)phosphonium (C10TPP) and its derivatives [30].

Fig 2.

Fig 2

Effect of mitoCCCP (2.5 μM) on the uncoupling activity of CCCP (A), SF6847 (B) or DNP (C) in rat liver mitochondria. Substrate: succinate. The membrane potential of mitochondria was estimated from changes in the absorbance of the potential sensitive dye safranine O (15 μM) at 555 nm and 523 nm. For other conditions, see Materials and methods.

To confirm the inhibitory effect of mitoCCCP on the CCCP-mediated uncoupling of RLM, we performed measurements of mitochondrial respiration, because the uncoupler-induced decrease of mitochondrial membrane potential is known to be accompanied by acceleration of mitochondrial respiration due to the dependence of the turnover rate of respiratory proton pumps on the membrane potential. As seen from Fig 3, blue curve, addition of 100 nM CCCP increased the respiration rate from 12 to 42. Remarkably, the subsequent addition of 2.5 μМ mitoCCCP suppressed the respiration rate to 22, which could be again augmented by the addition of ADP or DNP at a high concentration (80 μМ), thereby showing that the mitochondrial recoupling by mitoCCCP was not associated with inhibition of the respiratory chain. Similar to the observations on membrane potential, the DNP-induced stimulation of mitochondrial respiration, in contrast to the CCCP-induced uncoupling, was not removed by mitoCCCP (green curve, Fig 2). Insert to Fig 3 displays the effect of CCCP on the ADP/O ratio showing the stoichiometry of ATP synthetized per oxygen consumed. The ADP/O value decreased by CCCP was restored by mitoCCCP, thereby confirming its recoupling action.

Fig 3. Effect of mitoCCCP (2.5 μM) on the stimulation of succinate-driven respiration of rat liver mitochondria by CCCP (100 nM, blue curve) or by DNP (10 μM, green curve).

Fig 3

The three top traces show the stimulation of respiration by 100 μM ADP due to ATP synthesis. Insert: Recoupling effect of mitoCCCP on the ADP/O ratio (amount of ADP phosphorylated/O atom consumed). Shown are Mean±S.D. (n = 4). For experimental conditions, see Materials and Methods.

Similar to speculation on the mechanism of the recoupling action of 6-ketocholestanol [10, 11], it could be suggested that the recoupling activity of mitoCCCP is mediated by mitochondrial proteins. Alternatively, mitoCCCP, as a lipophilic cation derivative, could form inactive complexes with CCCP without participation of proteins, thereby resulting in a decrease in the CCCP concentration in solution, which could manifest itself as inhibition of the CCCP-mediated uncoupling. To examine this possibility, we studied impact of mitoCCCP on the CCCP-mediated proton current across planar bilayer lipid membrane (BLM) formed by the brush technique [27] (Fig 4A). The addition of mitoCCCP resulted in significant stimulation of the CCCP-mediated BLM current (blue curve in Fig 4), whereas mitoCCCP by itself did not elicit a noticeable BLM current (red curve in Fig 4), in agreement with the poor uncoupling effect of mitoCCCP on mitochondria. The mitoCCCP-caused stimulation of the CCCP-mediated BLM current was compatible with our previous data on the effect of lipophilic cations on the proton current induced by anionic uncouplers [30]. In addition, we performed experiments on liposomes loaded with the pH-sensitive fluorescent dye pyranine [29]. Fig 4B shows the kinetics of dissipation of pH gradient on the liposomal membranes after the addition of CCCP (60 nM, black curves), mitoCCCP (2 μM, red curve), and their combination (green curve). A slight acceleration of the CCCP-mediated proton flux was seen in the presence of mitoCCCP. Hence, in artificial lipid membrane systems (planar bilayers and liposomes), interaction between СССР and mitoCCCP could lead only to stimulation of the proton flow across lipid membranes, but not to suppression of the protonophoric activity of CCCP, as it was observed with mitochondria (Fig 2A).

Fig 4.

Fig 4

A. Effect of mitoCCCP (2.5 μM) on the CCCP (3 μM)—mediated electrical current through planar bilayer lipid membrane (BLM) made from DPhPC. The solution was 50 mM Tris, 50 mM MES, 10 mM KCl, 10 μg/ml EggPC liposomes, pH 7.4. The voltage applied to BLM was 50 mV. B. Effect of mitoCCCP (2 μM) on the CCCP (60 nM)–mediated proton fluxes through liposomes loaded with the pH-probe pyranine. Inner liposomal pH was estimated from the pyranine fluorescence intensities measured at 505 nm upon excitation at 455 nm. 1 μM lasalocid A was added at 600 s to equilibrate the pH. Other conditions: see Materials and Methods. Lipid concentration was 20 μg/ml.

Of note, when added at high concentrations (tens of micromoles), mitoCCCP caused mitochondrial uncoupling (decreased membrane potential and stimulated respiration, Fig 5), thereby manifesting itself as an uncoupler of a zwitterionic type, similar to protonophores described in [3133]. The zwitterionic protonophores are supposed to cross the membrane as a zwitterion in the deprotonated form and as a cation in the protonated form [33]. The weakness of the uncoupling activity of mitoCCCP in mitochondria might be associated with a much lower value of its pKa, 3.7 (S6 Fig in S1 File) compared to that of CCCP (5.95) [34, 35]. Surprisingly, with submitochondrial particles (SMP) isolated from bovine heart, mitoCCCP exhibited the pronounced uncoupling activity, as measured by both the NADH oxidation (Fig 6A and 6B) and the fluorescence response of the pH gradient-sensitive dye ACMA (Fig 6C). Fig 6A shows dependences of the rate of NADH oxidation by the respiratory electron transfer chain on the concentrations of mitoCCCP and CCCP. The concentration corresponding to half-maximum stimulation of respiration was about 400 nM for both compounds. The addition of mitoCCCP not only did not decelerate, but noticeably accelerate the NADH oxidation stimulated by CCCP (Fig 6B, right trace). Moreover, the pH gradient generated on SMP after the addition of NADH, manifesting itself in the quenching of ACMA fluorescence [26], was substantially decreased by 200 nM mitoCCCP (Fig 6C, red curve). The addition of 200 nM mitoCCCP after 200 nM CCCP led to an additional decrease in the pH gradient (black curve). Therefore, no recoupling was observed with mitoCCCP in SMP, in contrast to the case of mitochondria. In addition, we performed experiments with subbacterial particles from E. coli. The results were similar to those obtained with SMP, i.e. submicromolar concentrations of mitoCCCP induced depolarization of these vesicles and the addition of mitoCCCP after CCCP led to further reduction of the pH gradient (S7 Fig in S1 File). The effective concentrations of mitoCCCP in subbacterial particles were similar to those in SMP, i.e. hundreds of nanomolars.

Fig 5.

Fig 5

A. Dose dependence of respiratory stimulation by mitoCCCP with succinate as a substrate of mitochondria. Shown are Mean±S.D. (n = 4). For experimental conditions, see Materials and methods. B. Effect of mitoCCCP on the mitochondrial membrane potential in rat liver mitochondria (RLM) estimated by measuring absorbance changes of the potential-sensitive dye safranine O (15 μM). For experimental conditions, see Materials and methods. Insert: dose dependence of the effect of mitoCCCP on the membrane potential of RLM (Mean±S.D., n = 3).

Fig 6.

Fig 6

A. Concentration dependence of the effect of mitoCCCP (open circles) and CCCP (closed circles) on the NADH oxidation rate in submitochondrial particles (SMP). All the data are presented as mean ± SEM of at least 3 independent experiments. For experimental conditions, see Materials and methods. B. Traces of NADH oxidation by SMP in the presence of mitoCCCP and CCCP. Concentrations, left: mitoCCCP 0.45 μM, CCCP, 2.5 μM; right: CCCP, 1 μM, mitoCCCP, 0.45 μM. SMP concentration, 10 μg/ml. C. Effect of mitoCCCP and CCCP on the pH gradient across the membranes of submitochondrial particles (SMP), as measured by ACMA (0.5 μg/ml) fluorescence. Shown are traces of fluorescence at 480 nm (excited at 410 nm) in the medium containing 100 mM KCl, 10 mM HEPES, 5 mM MgCl2, 0.5 mM EGTA, pH 7.4. In the traces, 200 μM NADH was supplemented at t = 150 s. 1 μg/ml of gramicidin A was added at the end of each trace. Protein concentration was 25 μg/ml.

Thus, by conjugating the classical uncoupler CCCP with the lipophilic cation TPP, we obtained the compound that can block the CCCP-mediated uncoupling in mitochondria but not in SMP, and does not reduce the protonophoric activity of CCCP in protein-free lipid membranes, which may indicate participation of certain proteins in the mitochondrial uncoupling, as previously suggested [11]. This suggestion is compatible with the data on CCCP binding to mitochondrial proteins [36]. In particular, CCCP was shown to have high-affinity binding sites on cytochrome c oxidase, bc1 complex and H+-ATPase [37, 38], but whether these interactions contribute to the uncoupling was debated [9]. It can be speculated that mitoCCCP can bind to the same binding site/sites as CCCP, thereby preventing the protein-assisted protonophoric uncoupling mediated by CCCP, while mitoCCCP is a much weaker protonophore than CCCP according to our data.

Supporting information

S1 File

(DOC)

Acknowledgments

We are thankful to Elena Y. Pyrkova for technical assistance, and Anna S. Lapashina for providing subbacterial particles.

Abbreviations

FCCP

carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone

CCCP

carbonyl cyanide 3-chlorophenylhydrazone

SF6847 tyrphostin A9

3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile

DNP

2,4-dinitrophenol

BAM15

N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine

mitoCCCP

10-([4’-(dicyanomethylene)hydrazinyl-2’-chlorophenyl]oxy)decyl(triphenyl)phosphonium bromide

TPP

triphenylphosphonium

DPhPC

diphytanoylphosphatidylcholine

POPC

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

POPG

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol

EggPC

egg yolk phosphatidylcholine

RLM

rat liver mitochondria

BLM

bilayer lipid membrane

ΔΨ

mitochondrial membrane potential

SMP

submitochondrial particles

ACMA

9-amino-6-chloro-2-methoxyacridine

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was financially supported by the Russian Science Foundation, grant number 16-14-10025.

References

  • 1.Childress ES, Alexopoulos SJ, Hoehn KL, Santos WL. Small molecule mitochondrial uncouplers and their therapeutic potential. J. Med. Chem. 2018; 61: 4641–4655. 10.1021/acs.jmedchem.7b01182 [DOI] [PubMed] [Google Scholar]
  • 2.Kanemoto N, Okamoto T, Tanabe K, Shimada T, Minoshima H, Hidoh Y, et al. Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler. Nat. Commun. 2019; 10: 2172 10.1038/s41467-019-09911-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Demine S, Renard P, Arnould T. Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases. Cells 2019; 8: E795 10.3390/cells8080795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Antonenko YN, Khailova LS, Rokitskaya TI, Nosikova ES, Nazarov PA, Luzina OA, et al. Mechanism of action of an old antibiotic revisited: role of calcium ions in protonophoric activity of usnic acid. Biochim. Biophys. Acta Bioenerg. 2019; 1860: 310–316. 10.1016/j.bbabio.2019.01.005 [DOI] [PubMed] [Google Scholar]
  • 5.Antonenko YN, Denisov SS, Silachev DN, Khailova LS, Jankauskas SS, Rokitskaya TI, et al. A long-linker conjugate of fluorescein and triphenylphosphonium as mitochondria-targeted uncoupler and fluorescent neuro- and nephroprotector. Biochim. Biophys. Acta 2016; 1860: 2463–2473. 10.1016/j.bbagen.2016.07.014 [DOI] [PubMed] [Google Scholar]
  • 6.Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 2015; 347: 1253–1256. 10.1126/science.aaa0672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Feng X, Zhu W, Schurig-Briccio LA, Lindert S, Shoen C, Hitchings R, et al. Antiinfectives targeting enzymes and the proton motive force. Proc. Natl. Acad. Sci. U.S.A 2015; 112: E7073–E7082. 10.1073/pnas.1521988112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cunha FM, Caldeira da Silva CC, Cerqueira FM, Kowaltowski AJ. Mild mitochondrial uncoupling as a therapeutic strategy. Curr. Drug Targets 2011; 12: 783–789. 10.2174/138945011795528778 [DOI] [PubMed] [Google Scholar]
  • 9.Skulachev VP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim. Biophys. Acta 1998; 1363: 100–124. 10.1016/s0005-2728(97)00091-1 [DOI] [PubMed] [Google Scholar]
  • 10.Starkov AA, Dedukhova VI, Skulachev VP. 6-Ketocholestanol abolishes the effect of the most potent uncouplers of oxidative phosphorylation in mitochondria. FEBS Lett. 1994; 355: 305–308. 10.1016/0014-5793(94)01211-3 [DOI] [PubMed] [Google Scholar]
  • 11.Starkov AA, Bloch DA, Chernyak BV, Dedukhova VI, Mansurova SE, Severina II, et al. 6-Ketocholestanol is a recoupler for mitochondria, chromatophores and cytochrome oxidase proteoliposomes. Biochim. Biophys. Acta 1997; 1318: 159–172. 10.1016/s0005-2728(96)00134-x [DOI] [PubMed] [Google Scholar]
  • 12.Franklin JC, Cafiso DS. Internal electrostatic potentials in bilayers: measuring and controlling dipole potentials in lipid vesicles. Biophys. J. 1993; 65: 289–299. 10.1016/S0006-3495(93)81051-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cuéllar A, Ramirez J, Infante VM, Chavez E. Further studies on the recoupling effect of 6-ketocholestanol upon oxidative phosphorylation in uncoupled liver mitochondria. FEBS Lett. 1997; 411: 365–368. 10.1016/s0014-5793(97)00741-2 [DOI] [PubMed] [Google Scholar]
  • 14.Ligeret H, Barthelemy S, Bouchard DG, Carrupt PA, Tillement JP, Labidalle S, et al. Fluoride curcumin derivatives: new mitochondrial uncoupling agents. FEBS Lett. 2004; 569: 37–42. 10.1016/j.febslet.2004.05.032 [DOI] [PubMed] [Google Scholar]
  • 15.Dalla VL, Garcia-Argaez AN, Braga A, Martinez-Vazquez M, Grancara S, Martinis P, et al. An eudesman derivative from Verbesina persicifolia D.C. as a natural mild uncoupler in liver mitochondria. A new potential anti-obesity agent? Curr. Pharm. Des. 2014; 20: 253–261. 10.2174/13816128113199990028 [DOI] [PubMed] [Google Scholar]
  • 16.Figarola JL, Singhal J, Tompkins JD, Rogers GW, Warden C, Horne D, et al. SR4 uncouples mitochondrial oxidative phosphorylation, modulates AMP-dependent kinase (AMPK)-mammalian target of rapamycin (mTOR) signaling, and inhibits proliferation of HepG2 hepatocarcinoma cells. J. Biol. Chem. 2015; 290: 30321–30341. 10.1074/jbc.M115.686352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Urra FA, Cordova-Delgado M, Lapier M, Orellana-Manzano A, Acevedo-Arevalo L, Pessoa-Mahana H, et al. Small structural changes on a hydroquinone scaffold determine the complex I inhibition or uncoupling of tumoral oxidative phosphorylation. Toxicol. Appl. Pharmacol. 2016; 291: 46–57. 10.1016/j.taap.2015.12.005 [DOI] [PubMed] [Google Scholar]
  • 18.Firsov AM, Popova LB, Khailova LS, Nazarov PA, Kotova EA, Antonenko YN. Protonophoric action of BAM15 on planar bilayers, liposomes, mitochondria, bacteria and neurons. Bioelectrochemistry 2021; 137: 107673 10.1016/j.bioelechem.2020.107673 [DOI] [PubMed] [Google Scholar]
  • 19.Blaikie FH, Brown SE, Samuelsson LM, Brand MD, Smith RA, Murphy MP. Targeting dinitrophenol to mitochondria: limitations to the development of a self-limiting mitochondrial protonophore. Biosci. Rep. 2006; 26: 231–243. 10.1007/s10540-006-9018-8 [DOI] [PubMed] [Google Scholar]
  • 20.Johnson D, Lardy H. Isolation of liver or kidney mitochondria. Methods Enzymol. 1967; 10: 94–96. [Google Scholar]
  • 21.Antonenko YN, Denisov SS, Khailova LS, Nazarov PA, Rokitskaya TI, Tashlitsky VN, et al. Alkyl-substituted phenylamino derivatives of 7-nitrobenz-2-oxa-1,3-diazole as uncouplers of oxidative phosphorylation and antibacterial agents: involvement of membrane proteins in the uncoupling action. Biochim. Biophys. Acta 2017; 1859: 377–387. 10.1016/j.bbamem.2016.12.014 [DOI] [PubMed] [Google Scholar]
  • 22.Grivennikova VG, Gladyshev GV, Vinogradov AD. Deactivation of mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I): Extrinsically affecting factors. Biochim. Biophys. Acta Bioenerg. 2020; 1861: 148207 10.1016/j.bbabio.2020.148207 [DOI] [PubMed] [Google Scholar]
  • 23.Lapashina AS, Shugaeva TE, Berezina KM, Kholina TD, Feniouk BA. Amino acid residues b139, b189, and b319 modulate ADP-inhibition in Escherichia coli H+-FOF1-ATP synthase. Biochemistry (Moscow) 2019; 84: 407–415. [DOI] [PubMed] [Google Scholar]
  • 24.Chance B, Williams GR. A simple and rapid assay of oxidative phosphorylation, Nature 1955; 175: 1120–1121. 10.1038/1751120a0 [DOI] [PubMed] [Google Scholar]
  • 25.Akerman KE, Wikstrom MK. Safranine as a probe of the mitochondrial membrane potential. FEBS Lett. 1976; 68: 191–197. 10.1016/0014-5793(76)80434-6 [DOI] [PubMed] [Google Scholar]
  • 26.Deleage G, Penin F, Godinot C, Gautheron DC. Correlation between ATP hydrolysis, ATP synthesis, generation and utilization of delta ΔpH in mitochondrial ATPase-ATP synthase. Biochim. Biophys. Acta 1983; 725: 464–471. 10.1016/0005-2728(83)90187-1 [DOI] [PubMed] [Google Scholar]
  • 27.Mueller P, Rudin DO, Tien HT, Wescott WC. Methods for the formation of single bimolecular lipid membranes in aqueous solution. J. Phys. Chem. 1963; 67: 534–535. [Google Scholar]
  • 28.Denisov SS, Kotova EA, Khailova LS, Korshunova GA, Antonenko YN. Tuning the hydrophobicity overcomes unfavorable deprotonation making octylamino-substituted 7-nitrobenz-2-oxa-1,3-diazole (n-octylamino-NBD) a protonophore and uncoupler of oxidative phosphorylation in mitochondria. Bioelectrochemistry 2014; 98: 30–38. 10.1016/j.bioelechem.2014.02.002 [DOI] [PubMed] [Google Scholar]
  • 29.Chen Y, Schindler M, Simon SM. A mechanism for tamoxifen-mediated inhibition of acidification. J. Biol. Chem. 1999; 274: 18364–18373. 10.1074/jbc.274.26.18364 [DOI] [PubMed] [Google Scholar]
  • 30.Antonenko YN, Khailova LS, Knorre DA, Markova OV, Rokitskaya TI, Ilyasova TM, et al. Penetrating cations enhance uncoupling activity of anionic protonophores in mitochondria. PLOS ONE 2013; 8: e61902 10.1371/journal.pone.0061902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Biasutto L, Sassi N, Mattarei A, Marotta E, Cattelan P, Toninello A, et al. Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim. Biophys. Acta 2010; 1797: 189–196. 10.1016/j.bbabio.2009.10.001 [DOI] [PubMed] [Google Scholar]
  • 32.Denisov SS, Kotova EA, Plotnikov EY, Tikhonov AA, Zorov DB, Korshunova GA, et al. A mitochondria-targeted protonophoric uncoupler derived from fluorescein. Chem. Commun. 2014; 50: 15366–15369. 10.1039/c4cc04996a [DOI] [PubMed] [Google Scholar]
  • 33.Rokitskaya TI, Terekhova NV, Khailova LS, Kotova EA, Plotnikov EY, Zorov DB, et al. Zwitterionic protonophore derived from 2-(2-hydroxyaryl)alkenylphosphonium as an uncoupler of oxidative phosphorylation. Bioconjug. Chem. 2019; 30: 2435–2443. 10.1021/acs.bioconjchem.9b00516 [DOI] [PubMed] [Google Scholar]
  • 34.Heytler PG. Uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones. I. Some characteristics of m-Cl-CCP action on mitochondria and chloroplasts. Biochemistry 1963; 2: 357–361. 10.1021/bi00902a031 [DOI] [PubMed] [Google Scholar]
  • 35.Kasianowicz J, Benz R, McLaughlin S. The kinetic mechanism by which CCCP (carbonyl cyanide m-chlorophenylhydrazone) transports protons across membranes. J. Membr. Biol. 1984; 82: 179–190. 10.1007/BF01868942 [DOI] [PubMed] [Google Scholar]
  • 36.Starkov AA. "Mild" uncoupling of mitochondria. Biosci. Rep. 1997; 17: 273–279. 10.1023/a:1027380527769 [DOI] [PubMed] [Google Scholar]
  • 37.Katre NV, Wilson DF. Interaction of uncouplers with the mitochondrial membrane: identification of the high affinity binding site. Arch. Biochem. Biophys. 1978; 191: 647–656. 10.1016/0003-9861(78)90403-4 [DOI] [PubMed] [Google Scholar]
  • 38.Bona M, Antalík M, Gazová Z, Kuchár A, Dadák V, Podhradský D. Interaction of carbonyl cyanide 3-chlorophenylhydrazone with cytochrome c oxidase. Gen. Physiol. Biophys. 1993; 12: 533–542. [PubMed] [Google Scholar]

Decision Letter 0

Oleg Y Dmitriev

17 Jul 2020

PONE-D-20-17539

The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler

PLOS ONE

Dear Dr. Antonenko,

Thank you for submitting your manuscript to PLOS ONE.  Both reviewers and the editor concur that the findings reported in your paper merit publication, but several important points need to be addressed before the paper can be accepted. Therefore, we invite you to submit a revised version of the manuscript including some additional data and changes in response to the comments of the reviewers.

As noted by Reviewer #1, it is essential to examine the effect of mito-CCCP on the uncoupling activity of CCCP in mitoplasts,  and mitochondrial inner membrane  vesicles. Dependence of the recoupling effect of mito-CCCP on CCCP concentration, in mitochondria, and in these other membrane preparations, if recoupling is observed in the latter, should also be included in the revised manuscript. Please also address in the discussion  comments of Reviewer #2 regarding comparison between the effects of 6-ketocholestanol and mito-CCCP. Please respond to all other comments of the reviewers appended below.

Please submit your revised manuscript by Aug 31 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Oleg Y. Dmitriev, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In line with our guidelines on animal reporting please include the following:

•        Please specify the source from which animals were obtained

•        Please specify method of anaesthesia used.

•        Please specify the method of euthanasia.

•        Please complete and submit a copy of the ARRIVE Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://www.nc3rs.org.uk/arrive-guidelines.

Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article."

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

'This work was financially supported by the Russian Science Foundation, grant number 16-14-10025...'

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

'No'

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

  3. If any authors received a salary from any of your funders, please state which authors and which funders.

  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in your Competing Interests section: 'No'

a. Please complete your Competing Interests statement to state any Competing Interests.

If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

b. This information should be included in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

6. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

7. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a provocative paper that reports new data that suggests that the classical uncoupler CCCP operates in rat liver mitochondria by a mechanism that is distinct from its protonophore function. A derivative of CCCP, mito-CCCP has been synthsized and shown to effectively "recouple" mitochondria that have been decoupled by CCCP. The conclusion is that a protein-mediated mechanism of CCCP uncoupling should be considered. Protonophore activity of CCCP in both planar membanes and liposomes was not inhibited by mito-CCCP, nor was the uncoupling of mitochondria by DNP. The authors consider a direct complex formation between CCCP and mito-CCCP and conclude that this cannot be the explanation of the observed inhibition because the mito-CCCP accelerates the protonophore activity in model membrane systems. However, these data suggest there may be a direct interaction between the two compounds although a dramatic difference between model membranes and mitochondria must still be concluded. As far as it goes, this is a solid study and should be published. I suggest that the paper would be more complete if the authors also examined mitoplasts (inverted vesicles) and inverted E. coli vesicles to explore whether their observations apply to other biological membranes or inverted membranes. Since CCCP is clearly an potent protonophore the question is why this itself is not sufficient to result in uncoupling with mitochondria even if another protein-based mechanism is also operative. Concentration-dependence of CCCP on the ability to recouple by mito-CCCP might be instructive.

Reviewer #2: The authors have developed an interesting chemical tool; however, the mechanism remains incompletely understood and the paper would benefit from benchmarking to another recoupler.

1. Does mito-CCCP affect the lipid membrane dipole moment?

2. The authors should directly compare mito-CCCP to 6-ketocholestanol to better understand the difference between these recouplers. i.e. repeat figure 2A-C but with 6-ketocholestanol instead of mitoCCCP.

3. 6-KCh alters membrane dipole moment and this can block anion permeation alter hydration and phase behaviour of the membrane. Whether or not 6Kch blocks an uncoupler does not definitively mean that proteins are involved and the authors should thoroughly explain all possibilities. The authors only have 1 sentence on 6-Kch in the intro, which should be expanded into at least one paragraph that highlights what is known about this recoupler.

4. Does 6-KCh alter the activity of mito-CCCP over a dose-response of mitoCCCP?

5. Figures 2-3 use isolated mitochondria that can regenerate a proton gradient, while Fig 4B inovlves liposomes that cannot so there are multiple possibilities other than involvement of protein that may explain differences in compound activity in mitos vs liposomes. The authors should repeat figure 2A in the presence of non-respiring mitochondria treated with antimycin A and rotenone.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 30;15(12):e0244499. doi: 10.1371/journal.pone.0244499.r002

Author response to Decision Letter 0


14 Oct 2020

A.N.Belozersky Institute of Physico-Chemical Biology

Moscow State University

tel. +74-95-939-5149

fax +74-95-939-3181

Editorial Office

PLOS ONE

Moscow, 09.10.2020

Dear Professor Dmitriev,

thank you for reviewing our manuscript. According to your suggestions, we ran additional experiments on mitoplasts and sub-mitochondrial particles (SMP) as well as on sub-bacterial particles (SBP). While we observed similar recoupling effect of mitoCCCP in mitoplasts as in mitochondria, we did not observe the recoupling effect in case of membrane particles. Moreover, in contrast to mitochondria, mitoCCCP turns out to uncouple the particles at sub-micromolar concentrations (Fig.A below). We examined the dependence of the mitoCCCP recoupling on the concentration of CCCP and included it in the revised version. We feel that the effect of mitoCCCP on SMP/SBP is beyond the scope of our manuscript and we would like to publish these data in a separate paper along with the effect of other cationic conjugates of TPP with fluorescein and dinitrophenol.

We are grateful for critical evaluation of our manuscript by the reviewers. Please, find below our responses.

Reviewer #1

Comment.

This is a provocative paper that reports new data that suggests that the classical uncoupler CCCP operates in rat liver mitochondria by a mechanism that is distinct from its protonophore function. A derivative of CCCP, mito-CCCP has been synthsized and shown to effectively "recouple" mitochondria that have been decoupled by CCCP. The conclusion is that a protein-mediated mechanism of CCCP uncoupling should be considered. Protonophore activity of CCCP in both planar membanes and liposomes was not inhibited by mito-CCCP, nor was the uncoupling of mitochondria by DNP. The authors consider a direct complex formation between CCCP and mito-CCCP and conclude that this cannot be the explanation of the observed inhibition because the mito-CCCP accelerates the protonophore activity in model membrane systems. However, these data suggest there may be a direct interaction between the two compounds although a dramatic difference between model membranes and mitochondria must still be concluded. As far as it goes, this is a solid study and should be published.

Answer

Not required

Comment.

I suggest that the paper would be more complete if the authors also examined mitoplasts (inverted vesicles) and inverted E. coli vesicles to explore whether their observations apply to other biological membranes or inverted membranes.

Answer

We prepared mitoplasts and examined the effect of mitoCCCP on the CCCP-mediated decrease in the membrane potential. The effect was similar to that in mitochondria except the apparent transient character of the recoupling (Fig.S5 of the revised version). We speculate that the slow disappearance of the effect of mitoCCCP in case of mitoplasts could be accounted for by the limited tightness of the inner mitochondrial membrane induced by a stage of high-amplitude swelling of mitochondria during the procedure of the preparation of mitoplasts. In order to test the effect on the inverted vesicles of mitochondria, we ran experiments on sub-mitochondrial particles (SMP) from bovine heart provided by Dr.Vera Grivennikova (a Lab of Professor Vinogradov, Department of Biology, Moscow State University). Figure A below shows that the pH gradient generated on SMP after the addition of NADH can be substantially decreased by 60 nM mitoCCCP (red curve), the effect was similar to that of 200 nM CCCP (black curve). The addition of 60 nM mitoCCCP after 200 nM CCCP led to an additional decrease in the pH gradient (black curve). The effect of mitoCCCP cannot be attributed to inhibition of the respiratory chain of the SMP because the measurements of the rate of NADH consumption by absorbance at 340 nm shows a stimulation of the electron flow by this concentration of mitoCCCP (data not shown). As written above, we think that description of the strong uncoupling effect of mitoCCCP on SMP/SBP is beyond the scope of our manuscript and we would like to publish these data in a separate paper along with the effect of other cationic conjugates of TPP with fluorescein and dinitrophenol.

Fig. A. Effect of mitoCCCP and CCCP on the pH gradient on the membranes of sub-mitochondrial particles (SMP) measured by ACMA (0.5 µg/ml) fluorescence. Shown are traces of fluorescence in the medium containing 100 mM KCl, 10 mM HEPES, 5 mM MgCl2, 0.5 mM EGTA, pH 7.4. In the traces, 100 µM NADH was supplemented at t=180 s. Protein concentration was 25 µg/ml.

.

In addition to that we performed experiments with sub-bacterial particles (from E.coli) provided by Anna Lapashina (a Lab of Dr. Boris Feniouk, Department of Bioengeering and Bioinformatics, Moscow State University). The results were similar to those obtained with SMP, i.e. submicromolar concentrations of mitoCCCP induced depolarization of these vesicles and the addition of mitoCCCP after CCCP led to further reduction of the pH gradient.

Comment.

Since CCCP is clearly an potent protonophore the question is why this itself is not sufficient to result in uncoupling with mitochondria even if another protein-based mechanism is also operative.

Answer

This is a good question. The answer may be that the protonophoriс properties of CCCP on the lipid membrane are actually not so strong. It has been shown recently in our laboratory that triclosan exhibits much stronger protonophoric action on lipid membranes than CCCP while the uncoupling action of triclosan on mitochondria is substantially weaker than CCCP (Popova et al., BBA, 2018;1860(5):1000-1007. PMID: 29317196). This may indicate that the protonophoric action of CCCP by itself (I mean the action through lipid part of the inner mitochondrial membrane) is actually rather weak and it conducts protons predominantly via some mitochondrial membrane protein. In line with this we have found that the action of CCCP on mitochondria is strongly inhibited by bicarbonate anions (Khailova et al., BBRC 2020;530(1):29-34. PMID: 32828301).

Comment.

Concentration-dependence of CCCP on the ability to recouple by mito-CCCP might be instructive.

Answer

We measured the dependence of the effect of mitoCCCP on the concentration of CCCP and added these data in the revised version of our manuscript (Figure S4).

Reviewer #2

1. Comment.

Does mito-CCCP affect the lipid membrane dipole moment?

Answer

The answer to this question would require substantial piece of work using monolayer technique as well as planar bilayers. However as we wrote in the answer to comment #3 of the reviewer #2, this work is hardly relevant to our study.

2. Comment.

The authors should directly compare mito-CCCP to 6-ketocholestanol to better understand the difference between these recouplers. i.e. repeat figure 2A-C but with 6-ketocholestanol instead of mitoCCCP.

Answer

We confirmed the recoupling effect of 6-KCh in case of CCCP (as well as SF6847) in our experiments on mitochondria. Besides we can confirm that 6-KCh does not recouple in case of dinitrophenol. An example of the recoupling action of 6-KCh in case of FCCP has been published by us in (Antonenko et al., BBA 2016; 1860:2463-2473). Because the experiments proposed by the reviewer #2 would not show any new findings we prefer not to include them in our manuscript.

3. Comment.

6-KCh alters membrane dipole moment and this can block anion permeation alter hydration and phase behaviour of the membrane. Whether or not 6Kch blocks an uncoupler does not definitively mean that proteins are involved and the authors should thoroughly explain all possibilities. The authors only have 1 sentence on 6-Kch in the intro, which should be expanded into at least one paragraph that highlights what is known about this recoupler.

Answer

We added more information about 6-KCh in the introduction as suggested. In this regard, we would like to emphasize that in our opinion, the effect of 6-KCh on mitochondria is rather mysterious than understandable. The reviewer wrote that the major action of 6-KCh is the alteration of the dipole potential of the membrane which “can block anion permeation”. This is true with respect to dipole potential but definitely not true with respect to anion permeation. 6-Kch actually increases the dipole potential (Franklin and Cafiso, 1993, Biophys J., 65(1):289-299, PMID: 8396456) which increases the anion permeation in planar lipid bilayers. For example, it has been shown by Starkov et al. that 6-Kch increased the SF6847-mediated electrical current in BLM (Table 3 in Biochim Biophys Acta, 1997, 1318(1-2):159-172, PMID: 9030261). Therefore 6-KCh exerts the recoupling action (of say CCCP) on mitochondria in spite of facilitating anion permeation!

4. Comment.

Does 6-KCh alter the activity of mito-CCCP over a dose-response of mitoCCCP?

Answer

We tried to test the interference of 6-KCh and mitoCCCP if added one after another in experiments with membrane potential of RLM. Unfortunately we were not able to get a clear answer about the action of 6-KCh on the recoupling effect of mitoCCCP or vise versa. This question requires substantial efforts and we would like to leave it to future work.

5. Comment.

Figures 2-3 use isolated mitochondria that can regenerate a proton gradient, while Fig 4B inovlves liposomes that cannot so there are multiple possibilities other than involvement of protein that may explain differences in compound activity in mitos vs liposomes. The authors should repeat figure 2A in the presence of non-respiring mitochondria treated with antimycin A and rotenone.

Answer

Figure B below shows the data of an experiment as suggested by the reviewer #2. In this experiment a small amount of antimycin A was added after reaching the steady-state value of membrane potential at t=1 min. At t=3 min and t=4 min two portions of untreated RLM were added leading to an apparent rise in the membrane potential. Next we added 200 nM CCCP and 3 μM mitoCCCP. The recoupling effect of mitoCCCP is clearly seen in Figure B under these conditions. We think however that this result is hard to interpret and it does not clarify the mechanism of the recoupling action of mitoCCCP.

Fig. B. Effect of mitoCCCP (3 µM) on the uncoupling activity of CCCP in the presence of rat liver mitochondria treated with antimycin A. Substrate: succinate. At t=190 s and 260 s two additions of RLM (0.8 mg/ml) were supplemented. The membrane potential of mitochondria was estimated from changes in the absorbance of the potential sensitive dye safranine O (15 µM) at 555 nm and 523 nm. For other conditions, see Materials and methods.

Sincerely yours,

Yuri Antonenko

On behalf of all authors

Decision Letter 1

Oleg Y Dmitriev

2 Nov 2020

PONE-D-20-17539R1

The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler

PLOS ONE

Dear Dr. Antonenko,

Thank you for submitting your revised manuscript to PLOS ONE. While the authors have performed the additional experiments requested by the reviewers, they chose not to include the results in the revised manuscript. In my opinion, these results are essential for interpreting the "recoupling" effect of mito-CCCP and cannot be reasonably omitted from the paper. I would like to offer you another opportunity to revise your manuscript and include the results of investigating mito-CCCP activity in the membrane vesicles from mitochondria and bacteria. Without this data, I will have no choice but to reject the manuscript.  Considering the significance of the new data, the revised manuscript may have to undergo a full review. 

Please submit your revised manuscript by Dec 17 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Oleg Y. Dmitriev, Ph.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors describe a new compound that has recoupling properties. There are few other recouplers demonstrated in the literature so this paper is of interest. However, the authors incompletely characterize their molecule in terms of experiments and dose responses and so this paper is incomplete. The authors state they have some data that they want to save for another paper or don't want to show. It will be hard for other groups to use this molecule because this story is not complete and the authors have refused additional experiments necessary to understand it.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 30;15(12):e0244499. doi: 10.1371/journal.pone.0244499.r004

Author response to Decision Letter 1


23 Nov 2020

A.N.Belozersky Institute of Physico-Chemical Biology

Moscow State University

tel. +74-95-939-5149

fax +74-95-939-3181

Editorial Office

PLOS ONE

Moscow, 19.11.2020

Dear Professor Dmitriev,

According to your suggestion, we ran additional experiments on submitochondrial particles (SMP) and subbacterial particles (SBP) and included the results in the revised manuscript (new Fig.6 and Fig.S7 of ESI). We included Dr. Vera Grivennikova who ran most of the SMP experiments in the list of authors. We hope that the revised manuscript is now acceptable for publication in PLOS ONE.

Reviewer #2

Comment.

The authors describe a new compound that has recoupling properties. There are few other recouplers demonstrated in the literature so this paper is of interest. However, the authors incompletely characterize their molecule in terms of experiments and dose responses and so this paper is incomplete. The authors state they have some data that they want to save for another paper or don't want to show. It will be hard for other groups to use this molecule because this story is not complete and the authors have refused additional experiments necessary to understand it.

Answer

According to the suggestion, we ran additional experiments on submitochondrial particles (SMP) and subbacterial particles (SBP) and included the results in the revised manuscript (new Fig.6 and Fig.S7 of ESI).

Sincerely yours,

Yuri Antonenko

On behalf of all authors

Decision Letter 2

Oleg Y Dmitriev

11 Dec 2020

The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler

PONE-D-20-17539R2

Dear Dr. Antonenko,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. 

IMPORTANT: Please check all figures and make sure that dot and not comma is used as decimal separator.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Oleg Y. Dmitriev, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Oleg Y Dmitriev

18 Dec 2020

PONE-D-20-17539R2

The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler

Dear Dr. Antonenko:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Oleg Y. Dmitriev

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOC)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES